Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clazakizumab in Rheumatoid Arthritis
NCT00867516Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Oct 2008
- Primary completion
- Jun 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of clazakizumab in rheumatoid arthritis (RA), sponsored by CSL Limited. Started Oct 2008; status: completed.
02
Drugs
clazakizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00867516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867516.